| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.098 | 0.06 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |